Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cafcit
1. 69-22-7
2. Caffeine, Citrated
3. Cafcit
4. Caffeine Citrated
5. Citrated Caffeine
6. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Mixt. With 3,7-dihydro-1,3,7-trimethyl-1h-purine-2,6-dione
7. Caffeine Mixture With Citric Acid
8. U26eo4675q
9. 2-hydroxypropane-1,2,3-tricarboxylic Acid;1,3,7-trimethylpurine-2,6-dione
10. Ncgc00015208-09
11. Caffeina Citrate
12. Citrated Caffein
13. Dsstox_cid_26938
14. Dsstox_rid_82023
15. Dsstox_gsid_46938
16. Caffeine Citrate (1:1)
17. Cas-69-22-7
18. Caffeinecitrated
19. Caffeine, Citrated [nf]
20. Citric Acid, Compd. With Caffeine (1:1)
21. Unii-u26eo4675q
22. Cafcit (tn)
23. Caffeine Citrate (usp)
24. Caffeine-citric Acid 1/1
25. Schembl452067
26. Chembl1200569
27. Dtxsid5046938
28. Caffeine Citrate [mart.]
29. Citrated Caffeine [vandf]
30. Caffeine Citrate [who-dd]
31. Caffeine Citrate [ema Epar]
32. Nsc63248
33. Tox21_110099
34. Nsc-63248
35. Akos030254796
36. Caffeine Citrate [orange Book]
37. Tox21_110099_1
38. Caffeine Citrate [usp Impurity]
39. Ncgc00015208-19
40. 1,2,3-propanetricarboxylic Acid,2-hydroxy-,compounds,mixt. With 3,7-dihydro-1,3,7-trimethyl-1h-purine-2,6- Dione
41. Db-055239
42. Ft-0623368
43. Caffeine Mixture With Citric Acid [mi]
44. D07603
45. Q2974480
46. 3,7-dihydro-1,3,7-trimethyl-1h-purine-2,6-dione Citrate
47. 1,3,7-trimethyl-1h-purine-2,6(3h,7h)-dione 2-hydroxypropane-1,2,3-tricarboxylate
48. 1h-purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, 2-hydroxypropane-1,2,3-tricarboxylate
Molecular Weight | 386.31 g/mol |
---|---|
Molecular Formula | C14H18N4O9 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 5 |
Exact Mass | 386.10737816 g/mol |
Monoisotopic Mass | 386.10737816 g/mol |
Topological Polar Surface Area | 191 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 520 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Caffeine citrate |
PubMed Health | Caffeine Citrate |
Drug Classes | CNS Stimulant, Stimulant, Respiratory |
Drug Label | Both Caffeine Citrate Injection, USP for intravenous administration and Caffeine Citrate Oral Solution, USP are clear, colorless, sterile, non-pyrogenic, preservative-free, aqueous solutions adjusted to pH 4.7. Each mL contains 20 mg caffeine citrate... |
Active Ingredient | Caffeine citrate |
Dosage Form | Solution |
Route | Intravenous; Oral |
Strength | eq 30mg base/3ml (eq 10mg base/ml) |
Market Status | Prescription |
Company | Exela Pharma Science; Exela Pharma Scs; Fresenius Kabi Usa; Luitpold; Sagent Pharms; Sun Pharma Global |
2 of 2 | |
---|---|
Drug Name | Caffeine citrate |
PubMed Health | Caffeine Citrate |
Drug Classes | CNS Stimulant, Stimulant, Respiratory |
Drug Label | Both Caffeine Citrate Injection, USP for intravenous administration and Caffeine Citrate Oral Solution, USP are clear, colorless, sterile, non-pyrogenic, preservative-free, aqueous solutions adjusted to pH 4.7. Each mL contains 20 mg caffeine citrate... |
Active Ingredient | Caffeine citrate |
Dosage Form | Solution |
Route | Intravenous; Oral |
Strength | eq 30mg base/3ml (eq 10mg base/ml) |
Market Status | Prescription |
Company | Exela Pharma Science; Exela Pharma Scs; Fresenius Kabi Usa; Luitpold; Sagent Pharms; Sun Pharma Global |
Treatment of primary apnoea of premature newborns.
Central Nervous System Stimulants
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)
N06BC01
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Canada
Brand Name : PEYONA
Dosage Form : SOLUTION
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number : 2496771
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : CAFFEINE CITRATE ORAL SOLUTION USP
Dosage Form : SOLUTION
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number : 2526751
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : CAFFEINE CITRATE INJECTION USP
Dosage Form : SOLUTION
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number : 2526778
Regulatory Info :
Registration Country : Canada
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Brand Name : EXDOL-30
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging : 500
Approval Date :
Application Number :
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Brand Name : EXDOL-8
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging : 20/30/100
Approval Date :
Application Number :
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Brand Name : EXDOL-15
Dosage Form : TABLET
Dosage Strength : 30MG
Packaging : 100/500
Approval Date :
Application Number :
Regulatory Info : Narcotic (CDSA I)
Registration Country : Canada
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Cayona 20mg/ml
Dosage Form : INJ
Dosage Strength : 20mg
Packaging : 1X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Cayona 20mg/ml
Dosage Form : INJ
Dosage Strength : 20mg
Packaging : 1X10mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Related Excipient Companies
Global Sales Information
Market Place
ABOUT THIS PAGE
A Caffeine Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Caffeine Citrate, including repackagers and relabelers. The FDA regulates Caffeine Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Caffeine Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Caffeine Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Caffeine Citrate supplier is an individual or a company that provides Caffeine Citrate active pharmaceutical ingredient (API) or Caffeine Citrate finished formulations upon request. The Caffeine Citrate suppliers may include Caffeine Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Caffeine Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Caffeine Citrate written confirmation (Caffeine Citrate WC) is an official document issued by a regulatory agency to a Caffeine Citrate manufacturer, verifying that the manufacturing facility of a Caffeine Citrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Caffeine Citrate APIs or Caffeine Citrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Caffeine Citrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Caffeine Citrate suppliers with Written Confirmation (WC) on PharmaCompass.
Caffeine Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Caffeine Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Caffeine Citrate GMP manufacturer or Caffeine Citrate GMP API supplier for your needs.
A Caffeine Citrate CoA (Certificate of Analysis) is a formal document that attests to Caffeine Citrate's compliance with Caffeine Citrate specifications and serves as a tool for batch-level quality control.
Caffeine Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Caffeine Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Caffeine Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Caffeine Citrate EP), Caffeine Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Caffeine Citrate USP).
LOOKING FOR A SUPPLIER?